Veracyte (VCYT) Shares Outstanding (2012 - 2026)

Veracyte has disclosed Shares Outstanding (Entity) across 15 years of filings, most recently posting $80.4 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 2.25% year-over-year to $80.4 million; the TTM figure through Jun 2026 stood at $80.4 million (up 2.25% YoY), while the FY2025 annual figure was $79.4 million, up 2.04% from the prior year.
• Shares Outstanding (Entity) came in at $80.4 million for Q2 2026 at Veracyte, up from $79.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $80.4 million in Q2 2026 to a low of $71.4 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $75.7 million, with a median of $76.6 million recorded in 2024.
• The largest YoY upside for Shares Outstanding (Entity) was 6.24% in 2022 against a maximum downside of 1.0% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $72.0 million in 2022, then climbed by 1.81% to $73.3 million in 2023, then advanced by 6.15% to $77.8 million in 2024, then grew by 2.04% to $79.4 million in 2025, then climbed by 1.27% to $80.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $80.4 million in Q2 2026, $79.8 million in Q1 2026, and $79.4 million in Q4 2025.